Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 1, 2002, Pages 147-158

  Makino, Shinya ^a   Hashimoto, Kozo ^a   Gold, Philip W ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amygdala; Antidepressant; Bed nucleus of the stria terminalis; Corticosteroid receptor; Corticotropin releasing hormone; Neuropeptide Y; Paraventricular nucleus; Vasopressin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN FUNCTION; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEEDBACK SYSTEM; HORMONE DETERMINATION; HYPOTHALAMUS; IMMOBILIZATION STRESS; LOCUS CERULEUS; MENTAL STRESS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVIEW; STRESS; ANIMAL; BRAIN; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMAL; ANTIDEPRESSIVE AGENTS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; FEEDBACK, BIOCHEMICAL; HUMAN; STRESS; ANIMALS; HUMANS;

TERMINALIS;

EID: 0035985549     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00791-8     Document Type: Review

References (159)

1. Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain
2. Amygdalar participation in tonic ACTH secretion in the rat
3. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat
4. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
5. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior
6. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
7. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons
8. Control of ACTH secretion by the central nucleus of the amygdala: Implication of the serotonergic system and its relevance to the glucocorticoid delayed negative feedback mechanisms
9. Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence
10. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat
11. Roles of type I and type II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: Evidence for a nonadditive effect of combined receptor occupation
12. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice
13. Stress, antidepressant drugs, and the locus coeruleus
14. Long-term antidepressant administration alters corticotropin-releasing hormone and tyrosine hydroxylase, and mineralcorticoid receptor gene expression in rat brain
15. Dexamethasone resistance among nonhuman primates associated with a selective decrease of glucocorticoid receptors in the hippocampus and a history of social instability
16. Regulation of the autonomic nervous system by corticotropin-releasing factor
17. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus
18. Variations in maternal care in infancy regulate the development of stress reactivity
19. Restraint and stimulation of bed nucleus of the stria terminalis produce similar stress-like behaviors
20. The effect of social stress on hippocampal gene expression
21. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress
22. Modulation of hippocampal glucocorticoid and mineralcorticoid receptor mRNA expression by amygdaloid kindling
23. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1
24. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice
25. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
26. Pharmacological evidence that inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors
27. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis
28. Feast and famine: Critical role of glucocorticoids with insulin in daily energy flow
29. Are different parts of extended amygdala involved in fear versus anxiety?
30. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats
31. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: Relationship to subordinate status
32. Brain corticosteroid receptor balance in health and disease
33. Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function
34. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranscriptional mechanisms
35. Plasma corticosterone responses to electrical stimulation of the bed nucleus of the stria terminalis
36. The preoptic area and bed nucleus of the stria terminalis are involved in the effects of the amygdala on adrenocortical secretion
37. Differential effect of amygdaloid lesions of CRF-41, ACTH and corticosterone responses following neural stimuli
38. The neuroanatomical and neurochemical basis of conditioned fear
39. Psychological stress increases hippocampal mineralocorticoid receptor levels: Involvement of corticotropin-releasing hormone
40. The endocrinology of melancholic and atypical depression: Relation to neurocircuitry and somatic consequences
41. Clinical and biochemical manifestations of depression (two parts)
42. Autonomic neuropeptide connections of the amygdala
43. The organization and possible function of amygdaloid corticotropin-releasing factor pathways
44. Ibotonic acid lesions of the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone
45. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
46. Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats
47. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models
48. Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration
49. Corticotropin-releasing factor antagonists, binding-protein and receptors: Implications for central nervous system disorders
50. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action
51. The bed nucleus of the stria terminalis and immobilization-stress: Unit activity, escape behavior, and gastric pathology in rats
52. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system
53. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
54. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis
55. Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression
56. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression
57. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm
58. Defense of adrenocorticosteroid receptor expression in rat hippocampus: Effects of stress and strain
59. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526
60. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor
61. Rapid stress-induced elevations in corticotropin-releasing hormone mRNA in rat central amygdala nucleus and hypothalamic paraventricular nucleus: An in situ hybridization analysis
62. Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus
63. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis
64. Control of neuronal excitability by corticosteroid hormones
65. Hippocampal glucocorticoid receptor expression in the tree shrew: Regulation by psychosocial conflict
66. Hippocampal type I and type II corticosteroid receptors are differentially regulated by chronic prazosin treatment
67. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus
68. Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: Studies in primary amygdalar cultures
69. The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats
70. A sauvagene/corticotropin-releasing factor receptor expressed in heart and skeletal muscle
71. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
72. Neural regulation of corticotropin releasing hormone (CRH) and CRH receptor mRNA in the hypothalamic paraventricular nucleus in the rat
73. Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain
74. Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus
75. Corticotropin-releasing factor, norepinephrine, and stress
76. Corticosteroids in relation to fear, anxiety and psychopathology
77. Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus
78. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy
79. Adrenal and urinary catecholamines in rats during adaptation to repeated immobilization stress
80. Emotion and the amygdala
81. Role of hippocampus, the bed nucleus of the stria terminalis, and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex
82. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor
83. Lesions of central nucleus of the amygdala, but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex
84. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain
85. Stress-specific regulation of corticotropin-releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat
86. Hypothalamic and extrahypothalamic corticotropin-releasing hormone mRNA expression in cold stressed rats
87. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus
88. Effect of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; Comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus
89. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress
90. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels
91. Differential regulation of type-1 and type-2α corticotropin-releasing hormone receptor mRNA in the hypothalamic paraventricular nucleus of the rat
92. Decreased type-2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress
93. Psychological stress increased corticotropin-releasing hormone mRNA and content in the central nucleus of the amygdala but not in the hypothalamic paraventricular nucleus in the rat
94. Differential regulation of neuropeptide Y mRNA expression in the arcuate nucleus and locus coeruleus by stress and antidepressants
95. Lack of decrease in hypothalamic and hippocampal glucocorticoid receptor mRNA during starvation
96. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine hydroxylase gene expression in the locus coeruleus during repeated immobilization stress
97. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF
98. Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations
99. The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress
100. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala
101. Disruption of feeding behavior in CRH receptor 1-deficient mice is dependent on glucocorticoids
102. Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids
103. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
104. Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone
105. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001
106. Ultrashortloop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress
107. Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats
108. Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: A microdialysis study
109. Brainstem hemisection decreases corticotropin-releasing hormone mRNA in the paraventricular nucleus but not in the central amygdaloid nucleus
110. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy
111. The role of ascending neuronal pathways in stress-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats
112. Cloning and functional expression of a rat brain corticotropin-releasing factor (CRF) receptor
113. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in the heart
114. Increased of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis
115. Regulation of the hypothalamic-pituitary-adrenocortical system in mice deficient for CRH receptors 1 and 2
116. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients
117. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression
118. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulations
119. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
120. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
121. Increased stress-induced adrenocorticotropin response after long-term intracerebroventricular treatment of rats with antisense mineralocorticoid receptor oligodeoxynucleotides
122. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
123. Altered amygdalar CRF release and increased anxiety-like behavior in Sardinian alcohol-preferring rats: A microdialysis and behavioral study
124. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus
125. From normal fear to pathological anxiety
126. Stress down-regulates corticosterone receptors in a site-specific manner in the brain
127. Elevation of hypophyseal portal concentrations of adrenocorticotropin secretagogues after fornix transection
128. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus
129. Neuropeptides, the paraventricular nucleus, and the integration of hypothalamic neuroendocrine and autonomic function
130. Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat
131. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: Implication for understanding the states of fear and anxiety and allostatic load
132. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo
133. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central nucleus of the amygdala and anxiety-like behavior
134. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems
135. The role of CRF receptor subtypes in stress-induced behavioural responses
136. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
137. Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart
138. Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei
139. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat
140. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat
141. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor
142. Neurotransmitter modulation of glucocorticoid receptor mRNA levels in the rat hippocampus
143. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
144. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses
145. Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: Substrate for the co-ordination of emotional and cognitive limbs of the stress response
146. Amygdaloid lesions: Differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion
147. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity
148. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus
149. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
150. Regulation of glucocorticoid receptor protein and mRNA levels
151. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides
152. Osmotic stimulation differentially affects cellular levels of corticotropin-releasing hormone and neurotensin/neuromedin N mRNAs in the lateral hypothalamic area and central nucleus of the amygdala
153. The impact of physiological stimuli on the expression of corticotropin-releasing hormone (CRH) and other neuropeptide genes
154. Region specific regulation of neuropeptide mRNA levels in neurons of the limbic forebrain by adrenal steroids
155. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons
156. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
157. Contrasting effects of central alpha-1-adrenoreceptor activation on stress-responsive and stress-nonresponsive subpopulations of corticotropin-releasing hormone neurosecretory cells in the rat
158. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function
159. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated